Stoke Therapeutics, Inc. SEC filings STOK
Stoke Therapeutics, Inc. has 632 filings in SEC EDGAR's recent list, going back to Nov 24, 2014. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Aug 3, 2026 | — |
| S-8 | Employee stock plan registration | Aug 3, 2026 | — |
| S-3ASR | Automatic shelf registration | Mar 18, 2026 | — |
| S-8 | Employee stock plan registration | Mar 16, 2026 | — |
| S-8 | Employee stock plan registration | Jul 9, 2025 | — |
| S-3 | Shelf registration | Jul 9, 2025 | — |
| S-8 | Employee stock plan registration | Mar 18, 2025 | — |
| S-3ASR | Automatic shelf registration | Oct 9, 2024 | — |
| S-3 | Shelf registration | Jun 13, 2024 | — |
| S-8 | Employee stock plan registration | Apr 11, 2024 | — |
| 424B5 | Prospectus supplement | Mar 28, 2024 | — |
| FWP | Free writing prospectus | Mar 28, 2024 | — |
| 424B5 | Prospectus supplement | Mar 26, 2024 | — |
| S-8 | Employee stock plan registration | Apr 13, 2023 | — |
| S-8 | Employee stock plan registration | Mar 22, 2023 | — |
| S-3 | Shelf registration | May 20, 2022 | — |
| S-8 | Employee stock plan registration | Mar 14, 2022 | — |
| S-8 | Employee stock plan registration | Mar 19, 2021 | — |
| 424B5 | Prospectus supplement | Nov 20, 2020 | — |
| 424B5 | Prospectus supplement | Nov 18, 2020 | — |
| S-3 | Shelf registration | Jul 10, 2020 | — |
| S-8 | Employee stock plan registration | Mar 23, 2020 | — |
| 424B4 | Prospectus | Jun 19, 2019 | — |
| S-8 | Employee stock plan registration | Jun 19, 2019 | — |
| S-1MEF | Filing | Jun 18, 2019 | — |
| S-1/A | Amended registration statement | Jun 12, 2019 | — |
| S-1/A | Amended registration statement | Jun 7, 2019 | — |
| S-1 | Registration statement | May 23, 2019 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- STOK (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bedford, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1623526
- Former names
- ASOthera Pharmaceuticals, Inc. (until Nov 24, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.